Micronized Dietary Okara Fiber: Characterization, Antioxidant, Antihyperglycemic, Antihyperlipidemic, and Pancreato-Protective Effects in High Fat Diet/Streptozotocin-Induced Diabetes Mellitus. 2022

Yanping Huang, and Tolulope Joshua Ashaolu, and Opeyemi Joshua Olatunji
Department of Human Anatomy, Histology and Embryology, Anhui Medical College, Hefei 230601, China.

Diabetes mellitus (DM) is a lifelong devastating and debilitating disease with serious chronic complications. Okara is a byproduct generated from soymilk or tofu production and it has been reported to have antioxidant and lipid-lowering effects. However, the antidiabetic effects and pancreatic β-cells' secretory functions of micronized okara fiber (MOF) have not been reported. Therefore, this study explored the antidiabetic effects and modulatory potentials of MOF on pancreatic β-cells' secretory functions in a high fat/high sugar/streptozotocin rat model of diabetes mellitus. Fiber-rich okara was prepared by removing fat and proteins from freshly obtained okara, followed by micronization. Fiber-rich okara was prepared, micronized, and characterized for hydrophobicity, thermal stability, structure-function relationship, and antioxidant potentials. We then established a rat model of DM and MOF and two doses (100 and 400 mg kg-1) were administered to see its anti-DM effect. Four weeks of MOF supplementation significantly reduced blood glucose, increased serum insulin level, improved hepatorenal functions, glucose tolerance, and regenerated pancreatic β-cells in the treated DM rats. Furthermore, MOF significantly improved the pancreatic antioxidant defense system by significantly elevating glutathione peroxidase, catalase, and superoxide dismutase activities while depleting the malonaldehyde level in the pancreas of the treated diabetic rats. Our results indicated that MOF ameliorated DM by impeding hyperglycemia, hyperlipidemia, and oxidative stress and enhancing the secretory functions of the beta cells, suggesting that MOF might be used as a protective nutrient in DM.

UI MeSH Term Description Entries

Related Publications

Yanping Huang, and Tolulope Joshua Ashaolu, and Opeyemi Joshua Olatunji
March 2017, Chinese journal of natural medicines,
Yanping Huang, and Tolulope Joshua Ashaolu, and Opeyemi Joshua Olatunji
January 2022, Cardiovascular & hematological disorders drug targets,
Yanping Huang, and Tolulope Joshua Ashaolu, and Opeyemi Joshua Olatunji
September 2012, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie,
Yanping Huang, and Tolulope Joshua Ashaolu, and Opeyemi Joshua Olatunji
January 2012, Pharmacognosy magazine,
Yanping Huang, and Tolulope Joshua Ashaolu, and Opeyemi Joshua Olatunji
January 2020, Endocrine, metabolic & immune disorders drug targets,
Yanping Huang, and Tolulope Joshua Ashaolu, and Opeyemi Joshua Olatunji
October 2014, Journal of the science of food and agriculture,
Yanping Huang, and Tolulope Joshua Ashaolu, and Opeyemi Joshua Olatunji
July 2009, Indian journal of experimental biology,
Yanping Huang, and Tolulope Joshua Ashaolu, and Opeyemi Joshua Olatunji
June 2014, Pharmaceutical biology,
Yanping Huang, and Tolulope Joshua Ashaolu, and Opeyemi Joshua Olatunji
July 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
Yanping Huang, and Tolulope Joshua Ashaolu, and Opeyemi Joshua Olatunji
December 2022, Polish journal of veterinary sciences,
Copied contents to your clipboard!